DE69919327D1 - Prognostische allergie- oder entzündungstest - Google Patents
Prognostische allergie- oder entzündungstestInfo
- Publication number
- DE69919327D1 DE69919327D1 DE69919327T DE69919327T DE69919327D1 DE 69919327 D1 DE69919327 D1 DE 69919327D1 DE 69919327 T DE69919327 T DE 69919327T DE 69919327 T DE69919327 T DE 69919327T DE 69919327 D1 DE69919327 D1 DE 69919327D1
- Authority
- DE
- Germany
- Prior art keywords
- antibodies
- antigen
- child
- allergy
- peptides
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- 206010020751 Hypersensitivity Diseases 0.000 title abstract 3
- 230000007815 allergy Effects 0.000 title abstract 3
- 208000026935 allergic disease Diseases 0.000 title abstract 2
- 239000000427 antigen Substances 0.000 abstract 5
- 102000036639 antigens Human genes 0.000 abstract 5
- 108091007433 antigens Proteins 0.000 abstract 5
- 102000004196 processed proteins & peptides Human genes 0.000 abstract 3
- 108090000765 processed proteins & peptides Proteins 0.000 abstract 3
- 238000012216 screening Methods 0.000 abstract 2
- 208000004262 Food Hypersensitivity Diseases 0.000 abstract 1
- 206010016946 Food allergy Diseases 0.000 abstract 1
- 108060003951 Immunoglobulin Proteins 0.000 abstract 1
- 230000000172 allergic effect Effects 0.000 abstract 1
- 150000001413 amino acids Chemical class 0.000 abstract 1
- 208000010668 atopic eczema Diseases 0.000 abstract 1
- 238000011156 evaluation Methods 0.000 abstract 1
- 235000020932 food allergy Nutrition 0.000 abstract 1
- 239000012634 fragment Substances 0.000 abstract 1
- 102000018358 immunoglobulin Human genes 0.000 abstract 1
- 229940072221 immunoglobulins Drugs 0.000 abstract 1
- 208000027866 inflammatory disease Diseases 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 238000004393 prognosis Methods 0.000 abstract 1
- 102000004169 proteins and genes Human genes 0.000 abstract 1
- 108090000623 proteins and genes Proteins 0.000 abstract 1
- 230000002797 proteolythic effect Effects 0.000 abstract 1
- 238000010561 standard procedure Methods 0.000 abstract 1
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
- G01N33/5091—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing the pathological state of an organism
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6803—General methods of protein analysis not limited to specific proteins or families of proteins
- G01N33/6842—Proteomic analysis of subsets of protein mixtures with reduced complexity, e.g. membrane proteins, phosphoproteins, organelle proteins
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6854—Immunoglobulins
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6878—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids in epitope analysis
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/02—Nutritional disorders
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/24—Immunology or allergic disorders
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- Molecular Biology (AREA)
- Biomedical Technology (AREA)
- Chemical & Material Sciences (AREA)
- Hematology (AREA)
- Urology & Nephrology (AREA)
- Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- Microbiology (AREA)
- Cell Biology (AREA)
- Food Science & Technology (AREA)
- Medicinal Chemistry (AREA)
- Biotechnology (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Bioinformatics & Computational Biology (AREA)
- Biophysics (AREA)
- Tropical Medicine & Parasitology (AREA)
- Physiology (AREA)
- Virology (AREA)
- Peptides Or Proteins (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines Containing Plant Substances (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US7317198P | 1998-01-30 | 1998-01-30 | |
| US73171P | 1998-01-30 | ||
| PCT/US1999/001832 WO1999039211A1 (en) | 1998-01-30 | 1999-01-28 | Prognostic allergy or inflammation test |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| DE69919327T2 DE69919327T2 (de) | 2005-03-10 |
| DE69919327D1 true DE69919327D1 (de) | 2009-11-26 |
Family
ID=22112157
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DE69919327T Expired - Lifetime DE69919327D1 (de) | 1998-01-30 | 1999-01-28 | Prognostische allergie- oder entzündungstest |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US6238925B1 (enExample) |
| EP (2) | EP1051626B1 (enExample) |
| JP (1) | JP4292262B2 (enExample) |
| AT (2) | ATE426170T1 (enExample) |
| AU (1) | AU741635B2 (enExample) |
| CA (1) | CA2319317C (enExample) |
| DE (1) | DE69919327D1 (enExample) |
| ES (2) | ES2229673T3 (enExample) |
| WO (1) | WO1999039211A1 (enExample) |
Families Citing this family (24)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE10110838C2 (de) * | 2001-03-06 | 2003-04-03 | Mlu Halle Wittenberg | Verfahren zur Diagnostik von Allergien, Pseudoallergien und Intoleranzen |
| AU2002302410A1 (en) * | 2001-03-10 | 2002-09-24 | Affina Immuntechnik Gmbh | Method for identifying immune reactive epitopes on proteins |
| RU2214599C2 (ru) * | 2001-11-21 | 2003-10-20 | Самарский медицинский институт "РЕАВИЗ" | Способ выявления лиц, относящихся к группе риска по развитию аллергических заболеваний |
| MXPA05011409A (es) | 2003-04-23 | 2005-12-12 | Medarex Inc | Composiciones y metodos para la terapia de enfermedad inflamatoria intestinal. |
| PT1781705E (pt) | 2004-06-21 | 2014-12-23 | Medarex Llc | Anticorpos contra recetor i do interferão alfa e as suas utilizações |
| US8859210B2 (en) * | 2008-10-17 | 2014-10-14 | Mead Johnson Nutrition Company | Method for identifying allergenic proteins and peptides |
| JP5660027B2 (ja) * | 2009-03-05 | 2015-01-28 | 味の素株式会社 | クローン病診断試薬 |
| EP2478373B1 (en) * | 2009-09-14 | 2019-01-09 | Icahn School of Medicine at Mount Sinai | Methods for characterizing antibody binding affinity and epitope diversity in food allergy |
| WO2012135313A1 (en) * | 2011-03-28 | 2012-10-04 | University Of Massachusetts | Compositions and methods for detecting allergy to a-gal epitopes |
| EP2841098A4 (en) | 2012-04-23 | 2016-03-02 | Allertein Therapeutics Llc | NANOPARTICLES FOR THE TREATMENT OF ALLERGIES |
| JP2016516754A (ja) | 2013-04-03 | 2016-06-09 | アラーテイン・セラピューティクス・リミテッド・ライアビリティ・カンパニーＡｌｌｅｒｔｅｉｎ Ｔｈｅｒａｐｅｕｔｉｃｓ， ＬＬＣ | 新規のナノ粒子組成物 |
| KR102202575B1 (ko) | 2013-12-31 | 2021-01-13 | 삼성전자주식회사 | 메모리 관리 방법 및 장치 |
| US11215615B2 (en) | 2014-04-03 | 2022-01-04 | AllerGenis LLC | Peptides, reagents and methods for detecting food allergy |
| WO2016077808A1 (en) | 2014-11-14 | 2016-05-19 | Biomerica, Inc. | Compositions, devices, and methods of ibs sensitivity testing |
| EP3173789A1 (en) * | 2015-11-24 | 2017-05-31 | Helmholtz-Zentrum für Infektionsforschung GmbH | Method for differentiation of immune response in an individual |
| CA3062890A1 (en) * | 2016-04-26 | 2017-11-02 | Biomerica, Inc. | Compositions, devices, and methods of ulcerative colitis sensitivity testing |
| JP7062291B2 (ja) * | 2016-05-13 | 2022-05-16 | 応用酵素医学研究所株式会社 | アレルギー発症リスクを予測するためのデータを収集する方法 |
| RU2621312C1 (ru) * | 2016-06-15 | 2017-06-01 | Федеральное государственное автономное учреждение "Научный центр здоровья детей" Министерства здравоохранения Российской Федерации (ФГАУ "НЦЗД" Минздрава России) | Способ прогнозирования формирования толерантности при аллергии к белку коровьего молока у детей раннего возраста |
| KR102327467B1 (ko) * | 2016-06-16 | 2021-11-16 | 호유 가부시키가이샤 | 생선 알레르기의 항원 |
| CN109804247A (zh) | 2016-07-08 | 2019-05-24 | 拜尔梅里科有限公司 | 抑郁症敏感测试的组合物、设备以及方法 |
| CN110716055A (zh) * | 2019-09-11 | 2020-01-21 | 天津医科大学 | 过敏原特异性免疫球蛋白e致病活性检测试剂盒 |
| US11143650B1 (en) * | 2020-04-15 | 2021-10-12 | ProteinSimple | Method for measurement of total protein content and detection of protein via immunoassay in a microfluidic device |
| EP4212874A4 (en) * | 2020-09-07 | 2024-03-06 | Mitsubishi Gas Chemical Company, Inc. | METHOD FOR DETERMINING ALLERGIC DISEASES AND DETERMINATION SYSTEM |
| JP7555788B2 (ja) * | 2020-10-30 | 2024-09-25 | アサヒグループホールディングス株式会社 | タンパク質の起源種判別方法 |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5736362A (en) * | 1990-10-26 | 1998-04-07 | The University Of Melbourne | Ryegrass pollen allergen |
| US5567594A (en) | 1991-04-26 | 1996-10-22 | Enteron, L.P. | Methods and compositions for the detection and treatment of diseases associated with antigens of microorganisms |
| US5480972A (en) * | 1992-10-30 | 1996-01-02 | The University Of Melbourne | Allergenic proteins from Johnson grass pollen |
| US5558869A (en) * | 1992-12-30 | 1996-09-24 | University Of Arkansas | Major peanut allergen ara h II |
| ATE318902T1 (de) * | 1992-12-31 | 2006-03-15 | Immulogic Pharma Corp | Allergene proteine und peptide von hundhautanhangsgebilden und ihre verwendung |
-
1999
- 1999-01-28 EP EP99903464A patent/EP1051626B1/en not_active Expired - Lifetime
- 1999-01-28 JP JP2000529614A patent/JP4292262B2/ja not_active Expired - Fee Related
- 1999-01-28 ES ES99903464T patent/ES2229673T3/es not_active Expired - Lifetime
- 1999-01-28 AT AT99903464T patent/ATE426170T1/de not_active IP Right Cessation
- 1999-01-28 AT AT08005972T patent/ATE550665T1/de active
- 1999-01-28 AU AU23478/99A patent/AU741635B2/en not_active Ceased
- 1999-01-28 EP EP08005972A patent/EP1939628B1/en not_active Expired - Lifetime
- 1999-01-28 US US09/238,448 patent/US6238925B1/en not_active Expired - Lifetime
- 1999-01-28 CA CA002319317A patent/CA2319317C/en not_active Expired - Fee Related
- 1999-01-28 WO PCT/US1999/001832 patent/WO1999039211A1/en not_active Ceased
- 1999-01-28 DE DE69919327T patent/DE69919327D1/de not_active Expired - Lifetime
- 1999-01-28 ES ES08005972T patent/ES2383002T3/es not_active Expired - Lifetime
Also Published As
| Publication number | Publication date |
|---|---|
| HK1120865A1 (en) | 2009-04-09 |
| JP4292262B2 (ja) | 2009-07-08 |
| DE69919327T2 (de) | 2005-03-10 |
| ATE426170T1 (de) | 2009-04-15 |
| EP1939628A1 (en) | 2008-07-02 |
| AU741635B2 (en) | 2001-12-06 |
| US6238925B1 (en) | 2001-05-29 |
| WO1999039211A1 (en) | 1999-08-05 |
| CA2319317A1 (en) | 1999-08-05 |
| HK1032262A1 (en) | 2001-07-13 |
| JP2002502039A (ja) | 2002-01-22 |
| EP1051626A1 (en) | 2000-11-15 |
| ES2229673T3 (es) | 2009-08-04 |
| CA2319317C (en) | 2006-04-18 |
| AU2347899A (en) | 1999-08-16 |
| ES2383002T3 (es) | 2012-06-15 |
| EP1939628B1 (en) | 2012-03-21 |
| EP1051626B1 (en) | 2009-03-18 |
| ATE550665T1 (de) | 2012-04-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE69919327D1 (de) | Prognostische allergie- oder entzündungstest | |
| Erwin et al. | Quantitative measurement of IgE antibodies to purified allergens using streptavidin linked to a high-capacity solid phase | |
| RU2004136285A (ru) | Способ диагностики гепатоцеллюлярной карциномы | |
| Churchman et al. | Multiplexing immunoassays for cytokine detection in the serum of patients with rheumatoid arthritis: lack of sensitivity and interference by rheumatoid factor | |
| ATE152524T1 (de) | Antigene zusammensetzungen aus fragmenten von campylobacter pylori und verfahren zu ihrer herstellung und verwendung | |
| ATE126594T1 (de) | Verfahren zur herstellung des hochmolekulargewichtigen zell-verbundenen proteins von campylobakter pylori und seine verwendung zum serologischen nachweis von campylobakter pylori-infektionen. | |
| ATE134880T1 (de) | Bindung von immunkomplexen durch modifizierte formen von c-reaktiven proteinen | |
| EP0770679A3 (de) | HCV-spezifische Peptide, Mittel dazu und ihre Verwendung | |
| ATE474855T1 (de) | Polyklonaler-monoklonaler-elisa-assay zum nachweis von n-terminalem probnp | |
| ZA90136B (en) | Diagnostic test using chimeric antibodies | |
| Spiegelberg et al. | Lack of pokeweed mitogen-induced IgE formation in vitro by human peripheral blood mononuclear cells: detection of cross-reacting idiotypic determinants on polyclonal Ig by antibodies to a single IgE myeloma protein. | |
| KR20120004990A (ko) | 관절염 상태를 특성화하는 조성물 및 방법 | |
| DE50210021D1 (de) | Antikörper zum spezifischen Nachweis von pathogenen Prionen humanen Ursprungs und damit durchgeführte Nachweisverfahren | |
| ATE121788T1 (de) | Blutgerinnungsfaktor beta xiia monoklonale antikörper und immunanalyse. | |
| DE69112225D1 (de) | Immunodiagnostische probe für gelenkrheumatismus. | |
| DK0747481T3 (da) | Epstein-Barr-viruspeptider og antistoffer mod disse peptider | |
| ATE282830T1 (de) | Immuntest für human chromogranine a (cga), antikörper, reagenz und dazu geeigneter testsatz | |
| JPH10507266A (ja) | 体液中のコラーゲンの断片化パターンの評価とコラーゲンの代謝に関連する疾患の診断 | |
| DE60037115D1 (de) | Diagnostischer test für menschlisches matrix gla-protein und seine verwendung als biomarker | |
| Phillips et al. | Quantitative characterization of specificity and potency of conjugated antibody with solid-phase, antigen bead standards | |
| DK0526397T3 (da) | Immunologisk påvisningsfremgangsmåde | |
| ATE161851T1 (de) | Peptide mit für alpha-1-mikroglobulin charakteristischer antigener determinante | |
| DE602005025559D1 (de) | Diagnostischer Test für menschliches matrix Gla-Protein und seine Verwendung als Biomarker | |
| Antes et al. | Detection of C1q-bearing immune complexes by a monoclonal anti-C1q ELISA system | |
| KR102397684B1 (ko) | 항체의 항원 결합 부위에 결합하는 펩티드 및 이를 이용한 분석 방법 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| 8327 | Change in the person/name/address of the patent owner |
Owner name: SEER PHARAMACEUTICALS, LLC, FAIRFIELD, CONN., US |
|
| 8364 | No opposition during term of opposition | ||
| 8372 | Publication of ep patent withdrawn | ||
| 8380 | Miscellaneous part iii |
Free format text: DIE ERTEILUNG VOM 2.8.07 WURDE GELOESCHT. EPA HAT ERTEILUNG AUFGEHOBEN UND ERTEILUNGSVEROEFFENTLICHUNG GELOESCHT. |
|
| 8364 | No opposition during term of opposition |